概述

  • 产品名称
  • 描述
    兔多克隆抗体to CARKL
  • 经测试应用
    适用于: WB, ELISA, IHC-Pmore details
  • 种属反应性
    与反应: Mouse, Human
    预测可用于: Rat
  • 免疫原

    Synthetic peptide derived from the N-terminal of human CARKL.

  • 阳性对照
    • Human liver carcinoma tissue. Extracts from Jurkat cells.

性能

应用

Our Abpromise guarantee covers the use of ab69920 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB 1/500 - 1/1000. Detects a band of approximately 52 kDa (predicted molecular weight: 52 kDa).
ELISA 1/20000.
IHC-P 1/50 - 1/100.

靶标

Anti-CARKL antibody 图像

  • All lanes : Anti-CARKL antibody (ab69920) at 1/500 dilution

    Lane 1 : Extracts from Jurkat cells
    Lane 2 : Extracts from Jurkat cells with immunising peptide at 5 µg

    Lysates/proteins at 5 µg per lane.


    Predicted band size : 52 kDa
    Observed band size : 52 kDa
  • Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue using ab69920 at 1/50 dilution, in the presence and absence of immunising peptide.

Anti-CARKL antibody (ab69920)参考文献

This product has been referenced in:
  • Wamelink MM  et al. First two unrelated cases of isolated sedoheptulokinase deficiency: A benign disorder? J Inherit Metab Dis 38:889-94 (2015). WB . Read more (PubMed: 25647543) »
  • Haschemi A  et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab 15:813-26 (2012). WB ; Mouse . Read more (PubMed: 22682222) »

See all 2 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab69920.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册